A Study of the Use of Chartis System to Optimize Subject Selection for Endobronchial Lung Volume Reduction (ELVR)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01101958|
Recruitment Status : Completed
First Posted : April 12, 2010
Results First Posted : January 23, 2014
Last Update Posted : May 12, 2017
|Condition or disease||Intervention/treatment||Phase|
|Emphysema||Device: Chartis System Device: Endobronchial Valve (EBV) Treatment||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||96 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||A Study of the Use of Chartis System to Optimize Subject Selection for Endobronchial Lung Volume Reduction (ELVR) in Subjects With Heterogeneous Emphysema|
|Study Start Date :||January 2012|
|Actual Primary Completion Date :||March 2013|
|Actual Study Completion Date :||March 2013|
Chartis System-EBV Treatment
Subjects with heterogeneous emphysema, had their collateral ventilation status in the target treatment lobe assessed using the Chartis System (CV- or CV+) and underwent endobronchial lung volume reduction (ELVR) with endobronchial valves (EBV).
Device: Chartis System
The Chartis System provides a value that represents the quantification of the average resistance to airflow through collateral airways.
Device: Endobronchial Valve (EBV) Treatment
The endobronchial valve is designed to induce target lobe volume reduction.
- Lung Volume Change [ Time Frame: 30 Days ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01101958
|University of Heidelberg|
|Heidelberg, Germany, 69126|